Fig. 4From: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC visualizing multivariate proportional hazard cox regression model of factors associated with overall survival (OS) of metastatic NSCLC patientsBack to article page